Thomas C. Hall - Concepedia

Author

Thomas C. Hall

National Foundation for Cancer Research

Also Known As

Hall, Thomas C., Roy W. Beck, T C HALL, T C Hall, T Hall, T. C. HALL, T. C. Hall, T. Hall, T.C. Hall, THOMAS C. HALL

228

Publications

5.3K

Citations

H-Index

179

Concepts

All Affiliations

National Foundation for Cancer Research Harvard University University of Rochester Cancer Research Foundation Lemuel Shattuck Hospital

About

Thomas C. Hall is an author at National Foundation for Cancer Research specializing in medicine, oncology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	66	4K
2	Health Sciences	10	11	630
3	Natural Sciences	3	3	191
4	Engineering	2	2	95
5	Education	1	1	125

Thomas C. Hall

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
LACTIC DEHYDROGENASE IN HUMAN NEOPLASTIC TISSUES. Robert D. Goldman, Nathan O. Kaplan, Thomas C. Hall PubMed Tumor BiologyTumoral PathologyOncologyBiochemistryMedicine	1964	355
Vincristine treatment of advanced cancer: a cooperative study of 392 cases. James F. Holland, Carol Scharlau, Salman Gailani, PubMed Vincristine TreatmentPathologyPharmacotherapyMetronomic ChemotherapyNeuro-oncology	1973	236
VARIATIONS IN THE HUMAN PURKINJE CELL POPULATION ACCORDING TO AGE AND SEX Thomas C. Hall, A. K. H. MILLER, J Corsellis Neuropathology and Applied Neurobiology Brain DevelopmentSystematic MeasurementsTopographical AnatomyNeurobiology Of DiseaseLongevity	1975	226
Enzyme Activity in Invasive Tumors of Human Breast and Colon H.Bruce Bosmann, Thomas C. Hall Proceedings of the National Academy of Sciences Breast OncologyTumor InvasivenessGlycobiologyPathologyTumor Biology	1974	205
Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody. David M. Goldenberg, Jo Ann Horowitz, Robert M. Sharkey, Journal of Clinical Oncology Hematological MalignancyLl2 Immunoglobulin GLymphoid NeoplasiaMedicineMalignant Blood Disorder	1991	202
Use of glucocorticoids in the palliative treatment of metastatic brain tumors Neil B. Ruderman, Thomas C. Hall Cancer Tumor InnervationPathologyHigh-grade GliomasBrain LesionPalliative Treatment	1965	157
Transport and Phosphorylation as Factors in the Antitumor Action of Cytosine Arabinoside David Kessel, Thomas C. Hall, I Wodinsky Science Cell DeathPharmacotherapyDifferent Transplantable LeukemiasCellular PhysiologyTumor Biology	1967	127
Specific estrogen-binding capacity of the cytoplasmic receptor in normal and neoplastic breast tissues of humans. James L. Wittliff, Russell Hilf, William F. Brooks, PubMed Breast OncologyGynecologyMammary Gland DevelopmentTumor BiologyHigh Specific Radioactivity	1972	126
EXPERIMENTAL HYPERSENSITIVITY IN THE RABBIT Louis Schwab, Frederick C. Moll, Thomas C. Hall, The Journal of Experimental Medicine Allergy MedicineImmunologyAllergenVeterinary ResearchEducation	1950	125
Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis. Dolph O. Adams, Thomas C. Hall, Z Steplewski, Proceedings of the National Academy of Sciences Tumor DestructionImmunologyPathologyImmunologic MechanismImmunotherapy	1984	122

Page 1